A. Y. Park Et Al. , "GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.," Nature immunology , vol.25, pp.282-293, 2024
Park, A. Y. Et Al. 2024. GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.. Nature immunology , vol.25 , 282-293.
Park, A. Y., Leney-Greene, M., Lynberg, M., Gabrielski, J. Q., Xu, X., Schwarz, B., ... Zheng, L.(2024). GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.. Nature immunology , vol.25, 282-293.
Park, Ann Et Al. "GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.," Nature immunology , vol.25, 282-293, 2024
Park, Ann Y. Et Al. "GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.." Nature immunology , vol.25, pp.282-293, 2024
Park, A. Y. Et Al. (2024) . "GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.." Nature immunology , vol.25, pp.282-293.
@article{article, author={Ann Y Park Et Al. }, title={GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.}, journal={Nature immunology}, year=2024, pages={282-293} }